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Summary.-We have previously documented the development and subsequent dis-
appearance ofcytolytic activity mediated by lymphocytes from lymph nodes draining
Moloney sarcomas destined either to regress or grow progressively. We now report
that these tumour-draining lymphnode cells (LNC) that were no longer cytotoxic,
spontaneously regenerated peak levels of killing after culture in vitro for 4 days in the
absence of exogenous tumour antigen. Cytolytic activity, which was antigenically
specific, was mediated by T lymphocytes. Resurgence of cytolytic activity in vitro was
accompanied by proliferative changes (DNA synthesis, blast transformation, cell
division) which peaked on the 3rd day of culture. Although normal, nonimmune LNC
underwent quantitatively similar proliferative changes in culture, the killing that
developed was weak and antigenically nonspecific. Transfer of cultured, tumour-
draining LNC to immunologically compromised, syngeneic mice conferred complete
protection from Moloney sarcoma progression. Adoptive transfer could be delayed
for 6 days after tumour induction without loss of protection. These results suggest
that there exists in Moloney sarcoma-bearing mice a mechanism that limits the
differentiation of pre-killer cells into cytolytically active T lymphocytes, and that
such inhibition is eliminated when LNC are explanted into culture.
THE PRESENCE of cytolytic T lympho-
cytes in regressing Moloney sarcomas has
been documented in a number of different
laboratories (Plata et al., 1976; Holden et
al., 1976; Gillespie et al., 1977). We have
additionally shown that T cells with lytic
activity can be isolated directly from pro-
gressing Moloney sarcomas, but only dur-
ing the early stages of tumour develop-
ment (Gillespie et al., 1977). Thereafter, T
lymphocytes recovered either from pro-
gressing sarcomas or from the lymph
nodes draining these lesions lacked the
ability to kill (Gillespie and Russell, 1978).
Whennon-cytolyticlymphnode cells (LNC)
draining large progressing Moloney sar-
comas were explanted into culture, they
developed the capacity to kill again, in the
absence of exogenous antigen. This re-
surgence of cytolytic activity was in-
hibited, however, by the presence ofeither
soluble tumour antigen, macrophages (MO)
or a combination of antigen and MO.
"Spontaneous" reactivation of cytolytic
activity has beenreportedfor lymphocytes
from tumour-bearing or tumour-immune
animals following overnight incubation
(Sudo and Hashimoto, 1971; DeLandazuri
and Herberman, 1972; Vasudevan et al.,
1973, Laux and Lausch, 1974; Kamat and
Henney, 1976, 1977) or after repeated
washing (Currie and Basham, 1972). This
rapid augmentation of cytolytic activity
could be the result of a number offactors:
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removal of the inhibitory influence of
excess soluble antigen (Alexander et al.,
1969; Baldwin et al., 1973) or loss of
suppression mediated either by T lympho-
cytes (Kuperman et al., 1975; Fujimoto
et al., 1976; Takei et al., 1977) or by macro-
phages (Parkhouse and Dutton, 1966;
Kirchner et al., 1974; Wing and Reming-
ton, 1977).
Because the continued presence of cyto-
lytic T lymphocytes in vivo may contri-
bute to host resistance to tumour cell-
growth, we wanted to understand better
the phenomenon by which lytic activity
was regained in vitro, once it had been lost
in in vivo. We also wanted to determine
the degree of protection against tumour
progression conferred by cultured cells
when they were transferred adoptively to
immunologically compromised recipients.
The results of our studies, which included
lymphocytes derived from mice bearing
regressing as well as progressing Moloney
sarcomas, are reported here.
MATERIALS AND METHODS
Tumours and tumour-cell lines.-Regressing
or progressing Moloney sarcomas were in-
duced predictably in adult (6 or 8-week-old)
BALB/c AnCr male mice by the i.m. (gastroc-
nemius) injection of 5 x 103 or 106 MSC cells,
respectively (Russell et al., 1976b). The MSC
cell line, used to induce Moloney sarcomas,
also served as the source of antigen-relevant
target cells in lymphocyte-mediated cytolysis
assays. Antigenically unrelated P815 masto-
cytoma cells were employed routinely to
detect non-specific killing. The specificity of
the lymphocyte-mediated cytolysis was in-
vestigated further in assays using 3 antigen-
irrelevant BALB/c cell lines established from
3-methylcholanthrene-induced fibrosarcomas.
Cell lines were maintained and cells harvested
from culture as previously described (Gillespie
et al., 1977).
Sources oflymphocytes.-Popliteal and lum-
bar lymph nodes draining regressing or pro-
gressing Moloney sarcomas, or axillary, in-
guinal, superficial cervical and brachial lymph
nodes pooled from uninjected adult BALB/c
AnCr male mice, were the source of regressor,
progressor and normal lymphnode cells re-
spectively. Lymphnodes were minced with
scalpel blades, and the fragments wN-ere tri-
turated gently in 15 ml of Hepes-buffered
(15 mM) MEM (H-MEM) using large-bore
(2-3 mm diam) 10ml pipette. LNC, freed
from fragments after trituration in 3 succes-
sive changes of H-MEM, were pooled and
washed twice by centrifugation (300 g, 6 min,
22°C) through fresh H-MEM. The final cell
pellet was resuspended in lymphocyte culture
medium to a concentration of 2-2-5 x 107
viable cells/ml, as determined by trypan-blue
exclusion. The viability of the cells handled
in this fashion alwrays exceeded 95%o. The
percentages of T and B lymphocytes were
determined by direct immunofluorescence
microscopy (Russell et al., 1976a; Gillespie
and Russell, 1978). Fe-receptor-bearing cells
(mostly B lymphocytes and some macro-
phages) were depleted by incubation of LNC
suspensions on monolayers of antibody-
sensitized sheep erythrocytes (Kedar et al.,
1974).
Lymphocyte culture.-LNC were cultured
in H-MEM containing penicillin and strepto-
mycin and supplemented with 15% filtered
(0-22 ,um pore size) heat-decomplemented
(56°C, 30 min) FBS (foetal bovine serum) and
5 x 10-5M 2-mercaptoethanol (2-ME). Eightv
to 100 x 106 viable LNC, suspended in 4 ml of
culture medium, were placed in each 60 x 15
mm plastic Petri dish (#5220, Lux Scientific
Corp., Thousand Oaks, Ca.) and incubated up
to 5 days in a humidified CO2 incubator at
37°C. After 24 h and 72 h incubation, 1 ml of
culture medium was added to each Petri dish.
Lymphocytes were harvested by flushing the
Petri dishes with serum-free H-MEM jetted
from a Pasteur pipette. Cultured LNC Nere
washedtwice with H-MEM, then resuspended
in H-MEM containing 10% filtered, heat-
decomplemented FBS for subsequent analyses
of proliferative and cytolytic activities.
Demonstration of proliferation. Prolifera-
tive activity ofcultured LNC was documented
by measuring the levels of DNA synthesis,
mitotic activity and blast transformation.
DNA-synthetic activity was estimated from
the amount of radioactivity incorporated per
106 viable LNC during a 3 h pulse with 1251-
iododeoxyuridine (1251I-UdR). Triplicate ali-
quots (1 ml) of viable LNC (2-3x 106 each)
were dispensed into 12 x 75 mm culture tubes
(Falcon #2054) containing 1 MtCi of 125J
IUdR (New England Nuclear, Boston, Ma;
sp. act. >2,000 Ci/mM) and fluorodeoxyuli-
dine (10-6M, final concentration). After in-
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cubation (3 h, 37°C) in a humidified, CO2
incubator, 3 ml of iced, phosphate-buffered
(pH 7.2) physiological saline (PBS) was added
to each tube to slow cell metabolism, and the
contents of each tube were deposited onto
cellulose-acetate membranes (045 ,um pore
size) by vacuum filtration. The cells retained
on the filter membranes were washed with
iced PBS, and lysed with 10 ml of iced tri-
chloroacetic acid (10%). After dehydration
of the retained material by washing with
absolute ethanol, the acid-precipitated radio-
activity was counted with an automatic gam-
ma scintillation spectrometer.
Mitotic activity was determined from the
percentage of mitotic figures in Giemsa-
stained cytocentrifuged preparations of LNC
cultured for 3 h in the presence ofvinblastine
(10-7 g/ml). Blastogenesis was assessed on the
basis of the percentage of cells with the
characteristic morphological appearance of
lymphoblasts, as determined by microscopic
inspection of Giemsa-stained cytocentrifuge
preparations made directly from cultured
LNC.
LNC-mediated cytolysis assay.-Cytotoxi-
city of lymphocyte populations was deter-
mined using a 51Cr-release assay, and the
cytotoxic activity of each preparation was
expressed as the number of lytic units (LU)
per 106 T lymphocytes. This assay and the
calculation of LU have been described pre-
viously (Gillespie et al., 1977; Gillespie and
Russell, 1978) and allow direct comparison of
the relative cytolytic activities of different
LNC populations.
Depletion of T lymphocytes in vivo.-Adult
BALB/c mice were thymectomized, rested for
2 weeks, then irradiated (y-irradiation, 60Co
source, 109 rad/min, 7 min) and reconstituted
with 15 x 106 syngeneic marrow cells that had
been treated with anti-theta and comple-
ment. These adult-thymectomized, irradiated,
marrow-reconstituted mice (ATxBM) were
used in experiments 30-60 days later. Animals
that hadthymic remnants revealedbynecrop-
sy at the end of each experiment were
excluded.
RESULTS
Lymphnode cells draining regressing sar-
comas behave in vitro similarly to those
draining progressing sarcomas
There were two objectives here: (1) to
determine whether lymphnode cells drain-
ing Moloney sarcomas late in the course of
regression would recover cytolytic activity
in vitro, and (2) if so, to compare their
response to that ofLNC draining progress-
ing Moloney sarcomas. As shown in Fig. 1,
regressor LNC responded similarly to pro-
gressor LNC. Peak levels of cytolytic
activity, reached in both types of LNC
cultures by the 4th day, were invariably
higher for regressor populations, provided
that the LNC cultures were initiated at the
same time after tumour induction. After 4
days, cytolytic activity declined to pre-
culture levels, usually within 8-11 days
after cultures were started (data not
shown).
The killing that developed in culture
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FIG. 1. Resurgence of cytolytic activity
against MSC target cells and mediated by
lymphocytes from popliteal and lumbar
lymph nodes draining regressing (U * )
or progressing (O -- - 0) Moloney sarco-
mas. Antigenically unrelated P815 masto-
cytoma cells were not killed in parallel
experiments.
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FIG. 2. (a) Proliferative activity oftumour-draining LNC, as determinedbyassays for DNA synthesis,
cell division and blast transformation, increasing to a maximum at 3 days in culture. (b) Percent-
ages ofT (M) and B (HO) lymphocytes determined from direct immunofluorescence analyses of LNC
suspensions before and after culture. Numbers of LNC recovered at daily intervals from replicate
cultures are expressed as the percent of total cells initially cultured.
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FIG. 3. (a) DNA synthesis and blast transformation of cultured, non-immune LNC increasing slowly
to maximum levels at 5 days. At that time, low levels ofcytolytic activity, expressed as the number
oflytic units/106 T cells were detectable against both antigenically relevant (MSC E) and irrelevant
(P815w) cells. (b) Percentages of T (M) and B (0) lymphocytes determined from direct immuno-
fluorescence analyses ofLNC suspensions cultured from normal, non-immune mice; numbers ofLNC
recovered from replicate cultures at the specified intervals are expressed as the percent of total cells
initially cultured.
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was antigenically specific. The MSC cell.
which had been used to induce the tum-
ours, was killed efficiently. By compari-
son, cultured LNC were minimally cyto-
lytic to cells from 3 antigenically dis-
similar BALB/c sarcoma cell lines.
Resurgence of cytolytic activity in vitro was
T-lymnphocyte-dependent and associated with
proliferation
The killer cells generated in culture were
T lymphocytes; cytolytic activity was
abolished by treatment of cultured LNC
with anti-theta serum and complement.
Similar treatment with complement alone
had no effect. Cytolytic activity that de-
veloped was susceptible to anti-theta
treatment irrespective of whether cultures
were initiated with cells taken from lymph
nodes draining regressing or progressing
sarcomas.
Proliferative activity, documented by:
(1) uptakeof125I-IUdR into newlysynthe-
sized DNA, (2) counting of mitotic figures
in cultures exposed for 3 h to vinblastine,
and (3) quantification of blast cells in
Giemsa-stained cytocentrifuge prepara-
tion, reached peak levels after 3 days of
culture (Fig. 2(a)), one day before the peak
of cytolytic activity. Cell proliferation was
insufficient, however, to keep pace with
cell losses that occurred in vitro. This fact
was reflected by the steadily declining
recovery values that were obtained as time
in culture increased (Fig. 2(b)). While they
were never as cytolytic, cultured LNC
from mice with progressing sarcomas were
closely similar quantitatively to cultured
regressor LNC with regard to percentages
of T and B lymphocytes, recovery, and
proliferative activity.
While development of cytolytic activity
by cultured LNC from tumour-bearing
mice may have required proliferation of
precursor killer cells, cell division per se
was not sufficient to induce cytolytic
activity in cultures of LNC from normal
mice. Indices ofproliferation on Day 5 had
reached levels comparable to those ob-
tained in 3 days using LNC from tumour-
bearing mice (Fig. 3(a)). In spite of com-
parable levels of proliferation, the cyto-
lytic activity measured was low (3.4 LU/
106 T cells vs MSC targets) and relatively
non-specific (2.2 LU/106 T cells vs P815
mastocytoma cells (Fig. 3(a)). By contrast,
the cytolytic activity mediated in this
same experiment by cultured regressor
LNC was 40, 181 and 82 LU/106 T cell vs
MSC cells, at 3, 4 and 5 days respectively,
without detectable killing of P815 targets.
Cell recoveries during the first days of
culture of normal LNC were poorer than
when LNC from tumoured mice were used
(Fig. 3(b)). Because of this fact, normal
LNC cultures were not monitored after
5 days.
Effect of culture conditions on cytolytic
activity
The 2-ME included in cultures was not
directly responsible for inducing the high
levels of killing which was directed at
MSC cells. This fact is shown in the Table,
where results are given from an experi-
ment in which normal and regressor LNC
were cultured either with or without 2-
ME. In the absence of 2-ME, cell losses for
both populations were increased, and pro-
liferative and cytolytic activities were
substantially reduced. The presence of 2-
ME (5 x 10-5M) accentuated the killing
capacity for tumour-draining LNC with-
out inducing significant levels of non--
specific cytoxicity. Under identical culture
conditions, 2-ME caused non-immune
LNC to develop a low but significant
cytolytic capability that was completely
non-specific.
Because macrophages had previously
been shown to inhibit the development of
cytotoxicity in vitro (Gillespie and Russell,
1978), we examined the effect ofremoving
the few M0 that were normally present in
our LNC populations, along with other
Fe-receptor-bearing types either before or
after culture. LNC suspensions depleted
of MO before culture mediated levels of
tumour-specific killing (43 and 55 LU/106
T cells after 2 and 4 days, respectively)
that were comparable to those of LNC
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TABLE.-Effect of 2-mercaptoethanol on resurgence of cytolysis mediated by cultured
lymphnode lymphocytes
Source of
lymphocytes
Regressor micet
Normal mice
% recovery of
2-ME A
(5 x 10-5M) Total cells T cells
- 27-8 41-1
+ 53-7 61-3
- 22-2 32-4
+ 63-8 76-0
* Lytic units/106 T lymphocytes.
t 11 days after tumour induction.
125IUdR uptake
(ct/min/106 cells)
9021 ± 535
21,877±486
993±54
46,928± 1378
Cytotoxicity* against
AISC P815
13 -5
48 -2
0
3 -3
0
1 -2
0
3 -1
a
t --oo --- f K-0--- - --- - - -0-- - 9-
c
4 7 9 13 17 2124 27
Days After Tumour Induction
FIG. 4. After 3 days in vitro, 15 x 106
tumour-draining LNC were administered
i.v. to ATxBM mice (interrupted lines) that
had received an i.m. inoculation of 5 x 103
MSC cells 1 (a), 3 (b) or 6 (c) days previously
(arrows). Tumours ceased growing and dis-
appeared in these animals, but continued
to grow progressively in groups of ATxBM
mice that received either physiological
saline or 15 x 106 similarly cultured LNC
from normal, non-immune mice (solidlines).
(from the same original preparation) that
were MO-depleted after culture (45 and 68
LU/106 T cells, respectively).
Cytotoxic, cultured immune LNC protected
against tumour progression in vivo
Cultured, tumour-draining LNC that were
adoptively transferred to thymectomized,
irradiated, marrow-reconstituted adult
mice conferred protection against lethal
tumour inocula. Lymphocytes were har-
vested from cultures at the peak of blasto-
genesis (Day 3) and administered i.v. to
ATxBM mice (15 x 106 LNC/mouse) that
had received an i.m. injection of 5 x 103
MSC cells, 1 3 or 6 days previously. Tum-
our growth was monitored at 2-4-day
intervals, and tumour size recorded as
previously described (Russell and Coch-
rane, 1974). Tumour size increased roughly
linearly in mice that received either
physiological saline or cultured, non-
immune LNC. Mice injected with cultured,
tumour-draining LNC rejected their tum-
ours completely, even with a period as long
as 6 days between tumour induction and
adoptive transfer (Fig. 4).
The minimum number of cultured,
tumour-draining LNC required to prevent
Moloney sarcoma progression in immuno-
logically compromised hosts was deter-
mined by administering 2, 4 or 8 x 106
cultured immune lymphocytes 1 day after
inoculation of 5 x 103 MSC cells. As
illustrated in Fig. 5, tumour growth in
mice receiving 2 x 106 cultured LNC was
not altered significantly from that in mice
injected with physiological saline (control).
Mice injected with 4 x106 cells all deve-
loped lethal neoplasms, but the rate of
growth was slowed in comparison with
that of the two former groups. Tumours
never developed in mice protected with
8 x 106 cultured LNC.
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F1G. 5.-Tumour growth monitored at 2-7-day intervals after 2 (Q), 4 (O) or 8 (A) x 106 cultured.
tumour-draining LNC (interrupted lines) or physiological saline (solid lines) was administered i.v.
to ATxBM male mice that had received an i.m. inoculation of 5 x 103 cells the day before.
DISCUSSION
Results of the experiments described
here and in earlier publications (Gillespie
et al., 1977; Gillespie and Russell, 1978)
allow 3 conclusions to be drawn about
tumour-T-lymphocyte interrelationships
in the Moloney system: (1) an in vivo con-
trol mechanism stops the production of
cytolytic T lymphocytes in lymphnodes
draining either regressing or progressing
Moloney sarcomas; (2) after they have
reached a non-cytolytic state, explanta-
tion of T lymphocytes from tumour-
draining lymph nodes into culture releases
them from whatever influence it is that
prevents the production of killer cells in
vivo, allowing a resurgence of cytolytic
activity in vitro: and (3) cytolytic cells
generated from non-cytolytic T lympho-
cytes in tumour-draining lymph nodes
have powerful protective effects against
tumour progression in vivo.
We have documented previously the
functional activity in vitro of T lympho-
cytes isolated directly from regressing or
progressing Moloney sarcomas, or from
the lymph nodes draining these tumours
(Gillespie etal., 1977; Gillespie and Russell,
1978). Early in tumour development,
specific cytotoxic activity was demon-
strable. T lymphocytes recovered later
were progressively less cytolytic, with
virtual loss of this ability coinciding with
either the onset of tumour progression or
the disappearance of regressing sarcomas.
In the experiments reported here, we
confirmed an earlier observation that non-
cytolytic T cells from the lymph nodes
draining progressing Moloney sarcomas
spontaneously regenerated their cytolytic
activity when cultured in vitro. We have
additionally shown that a similar response
follows the explantation of non-cytolytic
cells from lymph nodes that are draining
sarcomas in the advanced stages of re-
gression. In either case killing, which was
highly specific, was shown to be lympho-
cyte-dependent and increased to peak
levels after 4 days of culture. Increased
cytolytic activity of cultured LNC was
associated with markedproliferation (DNA
synthesis, blast transformation, cell divi-
sion), which was maximal by the 3rd
culture day. Both proliferative and cyto-
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toxic activities declined sharply after
their respective peak levels were attained.
Quantitatively, T lymphocyte populations
from lymph nodes draining regressing
Moloney sarcomas consistently reached
higher peak levels of cytotoxic activity tn
vitro than populations from mice bearing
progressing sarcomas. Proliferation per se
was not responsible for the production of
killer T cells, however, as unsensitized
LNC cultured under the same conditions
failed to develop comparable levels of
cytolysis, even though they did undergo
substantial proliferation in vitro.
These changes do not appear to be
unique to the Moloney system. Several
groups of investigators (Sudo and Hashi-
moto, 1971; DeLandazuri and Herber-
man, 1972; Vasudevan et al., 1973; Laux
and Lausch, 1974; Kamat and Henney,
1976, 1977) have observed that cytolytic
activity, mediated by T lymphocytes from
tumour-bearing or tumour-immune ani-
mals, was augmented significantly if they
were held in culture before challenging
them with target cells in vitro. It is not
possible to determine whether the resur-
gence of killing in the first 4 reports was
other than qualitatively similar to what
we observed, since full examinations of
the characteristics of the cells were not
made. Kamat and Henney (1976, 1977),
however, have described in detail a some-
what analogous phenomenon in an allo-
geneic situation. These workers concluded
that 24 h of incubation in vitro was suffi-
cient for the differentiation of pre-killer T
cells into cytolytic effector cells. This
differentiation process, which was depen-
dent upon protein synthesis but indepen-
dent of DNA synthesis or antigenic stimu-
lation, was shown to be distinct from the
antigen-driven pathway by which memory
cells are specifically activated in vitro.
This "spontaneous augmentation" of allo-
geneic T-cell-mediated killing was not
affected by addition of alloantigen, and
was greatest before and during the peak
in vivo response. Thereafter, antigenic
stimulation was required for a substantial
in vitro response (presumably via memory-
cell activation). By contrast, we have
observed that the dramatic in vitro re-
surgence of cytotoxicity that occurred 4-6
days after the peak cytolytic activity in
tumour-bearing mice was suppressed by
the addition of exogenous antigen to the
culture (Gillespie and Russell, 1978).
In an extension of their previous find-
ings, Djeu et al. (1976) established that
cooperation among T lymphocytes, com-
plement-receptor lymphocytes and macro-
phages was required for spontaneous re-
activation of killer cells after in vitro
incubation (16-24 h) of non-cytolytic
spleen cells from tumour-immune rats.
However, these reactivated killer cells
were not T lymphocytes, but were identi-
fied as complement-receptor lymphocytes.
Ourresults therefore mayresemble more
closely those obtained in a system using
hapten-conjugated spleen cells instead of
tumour cells as the inoculum (Starzinski-
Powitz et al., 1976). Specifically, cytolytic
T lymphocytes were demonstrated in-
consistently in lymph nodes draining
inoculation sites; however, when these
LNC were cultured for 48-72 h, potently
cytolytic T cells developed by a prolifera-
tion-dependent pathway. Subsequentwork
by these investigators has demonstrated
that in vitro differentiation of pre-killer T
cells into cytolytic effector cells is blocked
by a T lymphoblast that is cyclophos-
phamide-sensitive (Wagner et al., 1976;
Rollinghoff et al., 1977).
The mechanism responsible for regulat-
ing the development of killer T cells in
vivo remains unclear. To hypothesize a
single pathway is, perhaps, naive. For
example, we have shown that soluble
tumour antigen, macrophages, or a com-
bination oftheseinterferedwithresurgence
of cytolytic activity in vitro (Gillespie and
Russell, 1978). These observations are
consonant with a large body of evidence
that both excess tumour antigen (Alex-
ander et al., 1969; Currie and Basham,
1972; reviewed in Kamo and Friedman,
1977) or macrophages (Parkhouse and
Dutton, 1966; Kirchner et al., 1974; Wing
and Remington, 1977) can suppress anti-
372IN VITRO RESURGENCE OF T LYMPHOCYTE-MEDIATED KILLING 373
tumour responses in vitro and in vivo.
Clearly, these may not be the principal
factors for, as demonstrated in the experi-
ments reported here, lytic activity dimi-
nished spontaneously after the 4th day in
culture, in spite of the fact that tumour
cells (i.e. a source of new tumour antigen)
and Fc-receptor-bearing cells (including
MO) had been depleted. Loss of cytotoxic
activity in association with reduced pro-
liferative activity is a characteristic fea-
ture shared with the previously described
in vitro anti-hapten response (Starzinski-
Powitz et al., 1976) and the long-term
mixed-leucocyte culture system that has
been investigated so thoroughly by Mac-
Donald and his colleagues (1974 a, b; re-
viewed by Engers and MacDonald, 1975).
In view of these considerations, and since
the T lymphocyte was the predominant
cell type remaining in our experiments, we
are currently investigating the contribu-
tion that suppressor T cells generated in
v)itro during the proliferative phase may
have to the continued production of cyto-
lytic T cells.
The results of adoptive-transfer experi-
ments that we conducted suggest how
important continued production of killer
T cells might be to the survival oftumour-
bearing hosts. Cytolytic T lymphocytes,
generated in vitro from non-cytolytic pre-
cursor cells from lymph nodes draining
tumours, protected immunologically de-
ficient mice bearing Moloney sarcomas.
Sarcoma growth was slowed greatly by
4x 106 ofthese cells administered i.v., and
8 x 106 afforded complete protection, even
when tumours were allowed 6 days in
which to become established. These results
should not be interpreted to mean that
T-lymphocyte-mediated killing of neo-
plastic cells within the tumours was the
mechanism of protection. Several other
possibilities must be considered. For ex-
ample, in preliminary experiments (not
described) draining lymphnode T lympho-
cytes activated in vitro as we have de-
scribed had the capacity to activate
macrophages to become non-specifically
cytolytic for tumour cells. Such an indirect
mechanism may ultimately be shown to be
equally important to, or even more
important than, the direct mediation of
cytotoxicity.
Note added in proof: Schechter and
Feldman (1978, Israel J. Med. Sci., 14,
131) have observed that spleen cells
cultured in vitro from tumour (3LL)-
bearing C57BL/6 mice regenerated cyto-
lytic activity, and in Wynn-type transfer
experiments significantly delayed tumour
development.
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